Advances in development and application of influenza vaccines

J Chen, J Wang, J Zhang, H Ly - Frontiers in immunology, 2021 - frontiersin.org
Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …

New technologies for influenza vaccines

S Rockman, KL Laurie, S Parkes, A Wheatley, IG Barr - Microorganisms, 2020 - mdpi.com
Vaccine development has been hampered by the long lead times and the high cost required
to reach the market. The 2020 pandemic, caused by a new coronavirus (SARS-CoV-2) that …

Generation of a live attenuated influenza A vaccine by proteolysis targeting

L Si, Q Shen, J Li, L Chen, J Shen, X Xiao, H Bai… - Nature …, 2022 - nature.com
The usefulness of live attenuated virus vaccines has been limited by suboptimal
immunogenicity, safety concerns or cumbersome manufacturing processes and techniques …

Status and challenges for vaccination against avian H9N2 influenza virus in China

J Dong, Y Zhou, J Pu, L Liu - Life, 2022 - mdpi.com
In China, H9N2 avian influenza virus (AIV) has become widely prevalent in poultry, causing
huge economic losses after secondary infection with other pathogens. Importantly, H9N2 …

Equine influenza virus and vaccines

FS Oladunni, SO Oseni, L Martinez-Sobrido… - Viruses, 2021 - mdpi.com
Equine influenza virus (EIV) is a constantly evolving viral pathogen that is responsible for
yearly outbreaks of respiratory disease in horses termed equine influenza (EI). There is …

Characterization of codon usage pattern in SARS-CoV-2

W Hou - Virology journal, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health …

Precision vaccine development: cues from natural immunity

S Barman, D Soni, B Brook, E Nanishi… - Frontiers in …, 2022 - frontiersin.org
Traditional vaccine development against infectious diseases has been guided by the
overarching aim to generate efficacious vaccines normally indicated by an antibody and/or …

Emerging antiviral therapies and drugs for the treatment of influenza

J Wang, Y Sun, S Liu - Expert Opinion on Emerging Drugs, 2022 - Taylor & Francis
Introduction Both vaccines and antiviral drugs represent the mainstay for preventing and
treating influenza. However, approved M2 ion channel inhibitors, neuraminidase inhibitors …

Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo

A Nogales, T Aydillo, G Ávila-Pérez… - Frontiers in …, 2019 - frontiersin.org
Influenza viruses are important pathogens that affect multiple animal species, including
humans. There are four types of influenza viruses: A, B, C, and D (IAV, IBV, ICV, and IDV …

The dynamic interface of viruses with STATs

AR Harrison, GW Moseley - Journal of virology, 2020 - Am Soc Microbiol
Viruses commonly antagonize the antiviral type I interferon response by targeting signal
transducer and activator of transcription 1 (STAT1) and STAT2, key mediators of interferon …